These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
39 results:

  • 1. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR cancers.
    Liu F; Zhong F; Wu H; Che K; Shi J; Wu N; Fu Y; Wang Y; Hu J; Qian X; Fan X; Wang W; Wei J
    Oncologist; 2023 Mar; 28(3):e136-e144. PubMed ID: 36724040
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Bounding-Box Regression Model for colorectal Tumor Detection in CT Images Via Two Contrary Networks.
    Kim Y; Park S; Kim H; Kim SS; Lim JS; Kim S; Choi K; Seo H
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():3793-3796. PubMed ID: 36085607
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Laparoscopic Complete Mesocolic Excision Without Routine Gastro-Pancreatico-Colic Trunk Dissection: Survival Outcomes and Morbidity for 567 Cases.
    Battersby NJ; Wright H; Qureshi T; Parker T; Figueiredo N; Parvaiz A
    J Laparoendosc Adv Surg Tech A; 2022 Sep; 32(9):938-947. PubMed ID: 35723641
    [No Abstract]    [Full Text] [Related]  

  • 5. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]    [Full Text] [Related]  

  • 6. Epidural Analgesia and Recurrence after colorectal cancer Surgery: A Danish Retrospective Registry-based Cohort Study.
    Hasselager RP; Hallas J; Gögenur I
    Anesthesiology; 2022 Mar; 136(3):459-471. PubMed ID: 35045154
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deep learning for the prediction of early on-treatment response in metastatic colorectal cancer from serial medical imaging.
    Lu L; Dercle L; Zhao B; Schwartz LH
    Nat Commun; 2021 Nov; 12(1):6654. PubMed ID: 34789774
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    Langenbecks Arch Surg; 2022 Mar; 407(2):699-706. PubMed ID: 34741671
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
    Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
    Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study.
    Son J; Park IJ; Yang DH; Kim J; Kim KJ; Byeon JS; Hong SM; Kim YI; Kim JB; Lim SB; Yu CS; Kim JC
    Surg Endosc; 2022 Apr; 36(4):2445-2455. PubMed ID: 34009477
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Extent of Surgical Resection in Inflammatory Bowel Disease Associated colorectal cancer: a Population-Based Study.
    Bogach J; Pond G; Eskicioglu C; Simunovic M; Seow H
    J Gastrointest Surg; 2021 Oct; 25(10):2610-2618. PubMed ID: 33559097
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China.
    Abasse Kassim S; Tang W; Abbas M; Wu S; Meng Q; Zhang C; Li X; Chen R
    Cancer Epidemiol; 2019 Oct; 62():101565. PubMed ID: 31323459
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean cancer Patients.
    Kwon JH; Lee SC; Lee MA; Kim YJ; Kang JH; Kim JY; Lee HJ; Bae WK; Kim MJ; Chie EK; Kim J; Kim YH; Chung HC; Rha SY
    Cancer Res Treat; 2019 Jul; 51(3):851-860. PubMed ID: 31208165
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced colorectal cancer with Regarding to the Extent of Bladder Invasion.
    Yoshida T; Shida D; Taniguchi H; Tsukamoto S; Kanemitsu Y
    Ann Surg Oncol; 2019 May; 26(5):1569-1576. PubMed ID: 30847751
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Coordination of Care Around Surgery for Colon cancer: Insights From National Patterns of Physician Encounters With Medicare Beneficiaries.
    Lin SC; Regenbogen SE; Hollingsworth JM; Funk R; Adler-Milstein J
    J Oncol Pract; 2019 Feb; 15(2):e110-e121. PubMed ID: 30550373
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Immune checkpoint blockade resistance-related b2m hotspot mutations in microsatellite-unstable colorectal carcinoma.
    Yeon Yeon S; Jung SH; Jo YS; Choi EJ; Kim MS; Chung YJ; Lee SH
    Pathol Res Pract; 2019 Jan; 215(1):209-214. PubMed ID: 30503610
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center.
    Qin S; Liu GJ; Huang M; Huang J; Luo Y; Wen Y; Wang Y; Chen L
    Int J Hyperthermia; 2019; 36(1):36-43. PubMed ID: 30489175
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial.
    Hegewisch-Becker S; Nöpel-Dünnebacke S; Hinke A; Graeven U; Reinacher-Schick A; Hertel J; Lerchenmüller CA; Killing B; Depenbusch R; Al-Batran SE; Lange T; Dietrich G; Tannapfel A; Arnold D
    Eur J Cancer; 2018 Sep; 101():105-113. PubMed ID: 30036739
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy.
    Bostel T; Förster R; Schlampp I; Sprave T; Bruckner T; Nicolay NH; Welte SE; Debus J; Rief H
    Radiat Oncol; 2017 Jul; 12(1):115. PubMed ID: 28697786
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV colorectal cancer (COMVI Study).
    Yoshida Y; Naito M; Yamada T; Aisu N; Kojima D; Mera T; Tanaka T; Naito K; Yasumoto K; Kamigaki T; Gotoh S; Kodama S; Yamashita Y; Hasegawa S
    Anticancer Res; 2017 Jul; 37(7):3941-3946. PubMed ID: 28668898
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.